Amring Pharmaceuticals Inc. was born of a long legacy of trust, respect, and success. The company’s mission is to ensure that patients have seamless, timely access to high-quality niche generic and value-driven brand medications while providing excellent customer service at a reasonable cost.
Amring is a subsidiary of a privately held global specialty pharmaceutical company based in the Netherlands. Amring is partnered with well-established global biopharmaceutical companies and is uniquely positioned to leverage its expertise in bringing biotechnology derived medicines, sterile manufacturing and other state-of-the-art technologies to the marketplace.
With focus on supplying specialized and unique products in targeted markets, Amring offers a simple value proposition to customers, partners, and the pharmaceutical marketplace: Leverage every opportunity to meet specific customer demands with value-added medicines. The company’s customer service is second to none. The team forges relationships based on flexibility, trust, and personal attention because they realize your patients cannot wait for the medicines they need. Every day they keep in mind the fact that you serve patients.
Amring has strategically positioned itself to make and market affordable products. The company is well invested in the success it has achieved with desmopressin acetate and tranexamic acid and is expanding their reach into both institutional and retail markets with most recently launched isoproterenol, lamotrigine and timolol maleate. Amring is always actively seeking to enhance its portfolio and takes pride in the success of the suite of product varieties—from tablets and suppositories to injectables—that it offers to its customers.
The company’s leadership team brings noteworthy experience in generic pharmaceuticals and related industries. Amring’s senior pharmaceutical executives have proven success in building businesses from the ground up, a keen ability to quickly maximize global resources at a local level, and the commitment and experience to support long-term, sustainable relationships. The company’s broad capabilities can also fill the gaps in pharmaceutical development, manufacturing, marketing, and distribution.
Backed by a notable heritage of accomplishment in the pharmaceutical industry, Amring is poised to continue its growth by bringing more significant, high-quality pharmaceutical products to the marketplace.
For more information, visit amringusa.com